Management of Esophageal Food Impaction

Initial Assessment and Risk Stratification

• For patients with complete esophageal obstruction, emergent flexible endoscopy within 2-6 hours using the push technique as first-line therapy has a 90-97% success rate and is safer than previously thought, according to the American College of Gastroenterology 1
• Immediate evaluation priorities include assessing for complete versus partial obstruction, which requires emergent intervention due to aspiration and perforation risk, as recommended by the American College of Emergency Physicians 1
• Obtain complete blood count, C-reactive protein, blood gas analysis, and lactate to evaluate the patient's condition, as suggested by the American College of Gastroenterology 1
• Do not order contrast swallow studies as they increase aspiration risk and impair subsequent endoscopic visualization, according to the American College of Radiology 1
• Plain radiographs have limited utility with false-negative rates up to 85% and should not delay management, as stated by the American College of Radiology 1
• CT scan should be performed only if perforation or complications are suspected, with a sensitivity of 90-100% versus 32% for plain films, as recommended by the American College of Radiology 1

Endoscopic Management Algorithm

• For complete obstruction, emergent flexible endoscopy within 2-6 hours is recommended, according to the American Society for Gastrointestinal Endoscopy 1, 2
• For partial obstruction, urgent flexible endoscopy within 24 hours is suggested, as recommended by the American Society for Gastrointestinal Endoscopy 1
• The first-line approach is the push technique using air insufflation and gentle instrumental pushing into the stomach, which achieves a 90-97% success rate, according to the American Society for Gastrointestinal Endoscopy 1, 2
• If pushing fails, use retrieval techniques with baskets, snares, or grasping forceps as a second-line approach, as suggested by the American Society for Gastrointestinal Endoscopy 1
• Consider rigid endoscopy if flexible endoscopy fails, particularly for upper esophageal impactions, according to the American Society for Gastrointestinal Endoscopy 1

Pharmacologic Interventions

• Medications have a minimal role and should not delay endoscopy, as stated by the American College of Gastroenterology 1, 3
• Do not rely on fizzy drinks, baclofen, salbutamol, or benzodiazepines as there is no clear evidence they are helpful, according to the American College of Gastroenterology 1, 3
• Pharmacologic therapy should never delay definitive endoscopic management, as recommended by the American College of Gastroenterology 1, 3

Essential Diagnostic Workup During Index Endoscopy

• Obtain at least 6 biopsies from different esophageal sites during the initial endoscopy to evaluate for underlying conditions such as eosinophilic esophagitis (EoE), as recommended by the American Gastroenterological Association 1, 2, 3
• Common underlying conditions to evaluate include EoE, esophageal strictures, Schatzki rings, or webs, hiatus hernia, achalasia, and malignancy, according to the American Gastroenterological Association 1, 2, 3
• If the patient has been on proton pump inhibitors (PPIs), withhold them for at least 3 weeks before repeat endoscopy, as 51% of EoE patients enter histological remission on PPIs, potentially masking the diagnosis, as stated by the American Gastroenterological Association 2, 3

Follow-Up Protocol

• Before discharge, schedule outpatient review to confirm the underlying cause of food impaction, educate the patient about their condition, and institute appropriate therapy for any identified underlying disorder, as recommended by the American College of Gastroenterology 1
• If inadequate biopsies were obtained, arrange elective repeat endoscopy and ensure PPIs are withheld for at least 3 weeks before the procedure if EoE is suspected, according to the American Gastroenterological Association 1, 2, 3
• For confirmed EoE, initiate maintenance therapy with topical steroids, which significantly reduces recurrent food impaction risk, as recommended by the American Academy of Allergy, Asthma, and Immunology 2, 3

Critical Pitfalls to Avoid

• Failing to obtain diagnostic biopsies during the index endoscopy can lead to missed diagnoses in the majority of patients, as stated by the American Gastroenterological Association 1, 3
• Performing endoscopy while the patient is on PPIs can mask EoE, according to the American Gastroenterological Association 2, 3
• Delaying endoscopy for pharmacologic trials beyond 2-6 hours in complete obstruction can increase the risk of complications, as recommended by the American College of Emergency Physicians 1
• Not scheduling follow-up before discharge can result in patients lost to follow-up, according to the American College of Gastroenterology 1
• Being overly cautious about the push technique due to outdated safety concerns can delay effective treatment, as stated by the American Society for Gastrointestinal Endoscopy 1
• Clinicians should be aware of increased perforation risk during both food impaction and diagnostic endoscopy in patients with underlying EoE, though perforations remain rare and are typically partial tears manageable conservatively, as reported by the Journal of Allergy and Clinical Immunology 4, 5

Evidence‑Based Immediate Management of Acute Esophageal Food Bolus Impaction

Assessment and Risk Stratification

Endoscopic Management

Pharmacologic Interventions (What Not to Do)

Diagnostic Workup During Index Endoscopy

Follow‑Up Protocol

Management of Acute Esophageal Food Bolus Obstruction – Evidence‑Based Recommendations

1. Glucagon Is Not Recommended

2. Conservative Pharmacologic Measures Lack Supporting Evidence

3. Biopsy Strategy for Detecting Eosinophilic Esophagitis (EoE)

4. Avoid Delaying Endoscopy for Pharmacologic Trials

5. Maintenance Therapy After Confirmed EoE

6. Glucagon Contra‑indications and Dosing (Anaphylaxis Context)

Evidence‑Based Management of Food Bolus Impaction and Associated Esophageal Conditions

Pharmacologic Maintenance Therapy

Complication Rates and Safety

Guideline Recommendations for Management of Esophageal Food Bolus Obstruction

Diagnostic Workup

• Obtain at least six esophageal biopsies from multiple anatomical sites during the index endoscopy to detect eosinophilic esophagitis (EoE), which accounts for up to 46 % of food‑bolus obstructions; failure to biopsy occurs in roughly 73 % of cases and leads to missed diagnoses. 16

• Eosinophilic esophagitis is the most common benign cause of food‑bolus obstruction, representing up to 46 % of such presentations. 16

Pharmacologic Interventions

• Glucagon should not be used as a first‑line treatment for food‑bolus obstruction because it shows a 0 % response rate in patients with EoE (versus ~28 % in non‑EoE cases) and overall effectiveness is limited to about one‑third of cases, offering no justification for delaying definitive endoscopic therapy. 16

Proton‑Pump Inhibitor (PPI) Management

• Withhold PPIs for at least three weeks before repeat endoscopy when EoE is suspected, because approximately 51 % of EoE patients achieve histologic remission on PPIs, which can mask the disease by reducing eosinophil counts below the diagnostic threshold. 16

Follow‑Up and Maintenance Therapy

• Schedule an outpatient review before hospital discharge to confirm the underlying cause of the obstruction, provide patient education, and initiate appropriate therapy; lack of scheduled follow‑up is associated with recurrent admissions and missed diagnoses. 16

• If biopsies were insufficient at the index procedure, arrange an elective repeat endoscopy after a minimum three‑week PPI washout to obtain adequate tissue for diagnosis. 16

• For confirmed EoE, initiate maintenance topical corticosteroid therapy (e.g., fluticasone or budesonide); this is the only factor independently associated with preventing recurrence of food‑bolus impaction on multivariate analysis. 16